2. Academic Validation
  3. Regulation of the Hippo Pathway Transcription Factor TEAD

Regulation of the Hippo Pathway Transcription Factor TEAD

  • Trends Biochem Sci. 2017 Nov;42(11):862-872. doi: 10.1016/j.tibs.2017.09.003.
Kimberly C Lin 1,  Hyun Woo Park 2,  Kun-Liang Guan 3
Affiliations

Affiliations

  • 1 Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.
  • 2 Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.
  • 3 Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: [email protected].
PMID: 28964625 DOI: 10.1016/j.tibs.2017.09.003
Abstract

The TEAD transcription factor family is best known for transcriptional output of the Hippo signaling pathway and has been implicated in processes such as development, cell growth and proliferation, tissue homeostasis, and regeneration. Our understanding of the functional importance of TEADs has increased dramatically since its initial discovery three decades ago. The majority of our knowledge of TEADs is in the context of Hippo signaling as nuclear DNA-binding proteins passively activated by Yes-associated protein (YAP) and transcriptional activator with PDZ-binding domain (TAZ), transcription coactivators downstream of the Hippo pathway. However, recent studies suggest that TEAD itself is actively regulated. Here, we highlight evidence demonstrating Hippo-independent regulation of TEADs and the potential impacts these studies may have on new Cancer therapeutics.

Keywords

Hippo; TEAD; YAP/TAZ; cancer; cytoplasmic–nuclear shuttling.

Figures